These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32554066)

  • 1. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.
    Morlandt AB; Moore LS; Johnson AO; Smith CM; Stevens TM; Warram JM; MacDougall M; Rosenthal EL; Amm HM
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1736-1747. PubMed ID: 32554066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
    Miller SE; Tummers WS; Teraphongphom N; van den Berg NS; Hasan A; Ertsey RD; Nagpal S; Recht LD; Plowey ED; Vogel H; Harsh GR; Grant GA; Li GH; Rosenthal EL
    J Neurooncol; 2018 Aug; 139(1):135-143. PubMed ID: 29623552
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Stone LD; Massicano AVF; Stevens TM; Warram JM; Morlandt AB; Lapi SE; Amm HM
    Sci Rep; 2022 Nov; 12(1):19187. PubMed ID: 36357495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies.
    Chung TK; Warram J; Day KE; Hartman Y; Rosenthal EL
    Cancer Biol Ther; 2015; 16(5):790-8. PubMed ID: 25719497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.
    Moore LS; Rosenthal EL; de Boer E; Prince AC; Patel N; Richman JM; Morlandt AB; Carroll WR; Zinn KR; Warram JM
    Mol Imaging Biol; 2017 Aug; 19(4):610-616. PubMed ID: 27830425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
    Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
    Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2.
    van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J
    J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
    Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
    Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
    Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.
    Day KE; Beck LN; Heath CH; Huang CC; Zinn KR; Rosenthal EL
    Cancer Biol Ther; 2013 Mar; 14(3):271-7. PubMed ID: 23298904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.
    Aerts HJ; Dubois L; Perk L; Vermaelen P; van Dongen GA; Wouters BG; Lambin P
    J Nucl Med; 2009 Jan; 50(1):123-31. PubMed ID: 19091906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
    Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
    Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.
    Holzmann KLK; Wolf JL; Stangl S; Lennartz P; Kasajima A; Mogler C; Haller B; Ebert EV; Jira D; Lauterbach MLA; von Meyer F; Stark L; Mauch L; Schmidl B; Wollenberg B; Multhoff G; Wirth M
    Br J Cancer; 2024 Dec; 131(11):1814-1824. PubMed ID: 39406917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma.
    Cho N; Ko S; Shokeen M
    Mol Imaging Biol; 2021 Apr; 23(2):186-195. PubMed ID: 32964391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.